Pharmacological inhibition of hypoxia induced acidosis employing a CAIX inhibitor sensitizes gemcitabine resistant PDAC cells
Authors:
Open Access
- 14 May 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-16
Abstract
The poor prognosis of pancreatic ductal adenocarcinoma (PDAC) is attributed to tumor microenvironment driven by hypoxia regulated carbonic anhydrase IX. Our study elucidates the ability of Methazolamide, a CAIX inhibitor to sensitize resistant PDAC cells. The effect of Methazolamide alone and in combination with gemcitabine on proliferation, migration, tumor inhibition along with its impact on metastasis by influencing HIF-1α/PTEN/Glut1/Glut3 signalling through the expression of CAIX was assessed. Methazolamide induced cytotoxicity in several PDAC cells including patient derived with IC50 0.7–4.09 mM and 0.29–2.56 mM in monolayer and clonogenic assays respectively. Methazolamide alone and in combination significantly downregulated hypoxia induced expression of HIF-1α and CAIX together with proliferation (Ki-67, Cyclin D1), invasion (Rac-1, Snail), stem cell (Oct-4, Sox-2), angiogenesis (VEGF), glycolysis (Glut1, Glut3) and apoptosis (Bax, Bc1-2 and PTEN) markers in MIA PaCa-2 and PANC-1 cells. In vivo study in PAXF 546L PDX model exhibited profound tumor growth inhibition with downregulation of CD34, Oct-4, Sox-2, C-myc, Nanog, Ki-67, and Rac-1 signalling. Considering inadequate availability of effective therapeutics and importance of CAIX in processes leading to aggressive behavior of PDAC, targeting it by using Methazolamide, a pre-approved drug in combination with gemcitabine represents promising therapeutic approach specifically in metastatic settings.Keywords
This publication has 33 references indexed in Scilit:
- Influence of methazolamide on the human control of breathing: A comparison to acetazolamideExperimental Physiology, 2019
- Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to HypoxiaGastroenterology, 2019
- Glucose and Lactate Transport in Pancreatic Cancer: Glycolytic Metabolism RevisitedJournal of Oncology, 2018
- Cancer Drug Development of Carbonic Anhydrase Inhibitors beyond the Active SiteMolecules, 2018
- The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brainNeurobiology of Disease, 2016
- Targeting cancer cell metabolism in pancreatic adenocarcinomaOncotarget, 2015
- Whole genomes redefine the mutational landscape of pancreatic cancerNature, 2015
- Efficacy and Safety of Oral Methazolamide in Patients With Type 2 Diabetes: A 24-Week, Placebo-Controlled, Double-Blind StudyDiabetes Care, 2014
- Acute bilateral angle closure glaucoma induced by methazolamideClinical Ophthalmology, 2013
- Methazolamide 1% in cyclodextrin solution lowers IOP in human ocular hypertension.2000